50 related articles for article (PubMed ID: 9516124)
1. JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation.
Ogata N; Kouro T; Yamada A; Koike M; Hanai N; Ishikawa T; Takatsu K
Blood; 1998 Apr; 91(7):2264-71. PubMed ID: 9516124
[TBL] [Abstract][Full Text] [Related]
2. Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic Cellulitis.
Morot J; Del Duca E; Chastagner M; Fernandes M; Estrada Y; Lefevre MA; Kanitakis J; Harou O; Jullien D; Nicolas JF; Krueger JG; Vocanson M; Guttman-Yassky E; Villani AP
JAMA Dermatol; 2023 Aug; 159(8):820-829. PubMed ID: 37342057
[TBL] [Abstract][Full Text] [Related]
3. Molecular design and systematic optimization of a halogen-bonding system between the asthma interleukin-5 receptor and its cyclic peptide ligand.
He Q; Xu S; Ma X; Zhou Y; Feng W; Lu X; Yu M; Chen Z
Chem Biol Drug Des; 2024 Jan; 103(1):e14387. PubMed ID: 37926515
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human interleukin-2 in complex with TCB2, a new antibody-drug candidate with antitumor activity.
Kim J; Lee JY; Park SY; Lee YJ; Kim MS
Oncoimmunology; 2021 Mar; 10(1):1899671. PubMed ID: 33796411
[TBL] [Abstract][Full Text] [Related]
5. Structure of the interleukin-5 receptor complex exemplifies the organizing principle of common beta cytokine signaling.
Caveney NA; Rodriguez GE; Pollmann C; Meyer T; Borowska MT; Wilson SC; Wang N; Xiang X; Householder KD; Tao P; Su LL; Saxton RA; Piehler J; Garcia KC
Mol Cell; 2024 May; 84(10):1995-2005.e7. PubMed ID: 38614096
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5 levels in relation to malaria severity: a systematic review.
Kotepui M; Duangchan T; Mahittikorn A; Mekhora C; Anabire NG; Kotepui KU
Malar J; 2023 Aug; 22(1):226. PubMed ID: 37537570
[TBL] [Abstract][Full Text] [Related]
7. Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon.
Wang P; Mo Z; Zhang Y; Guo C; Chikede TK; Chen D; Lei Z; Gao Z; Zhang Q; Tong Q
Front Immunol; 2022; 13():1104329. PubMed ID: 36685563
[TBL] [Abstract][Full Text] [Related]
8. Th2 Cytokines (Interleukin-5 and -9) Polymorphism Affects the Response to Anti-TNF Treatment in Polish Patients with Ankylosing Spondylitis.
Biały S; Iwaszko M; Świerkot J; Bugaj B; Kolossa K; Jeka S; Bogunia-Kubik K
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361964
[TBL] [Abstract][Full Text] [Related]
9. Taking a Breather: Advances in Interleukin 5 Inhibition for Asthma Relief.
Massey OW; Suphioglu C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232470
[TBL] [Abstract][Full Text] [Related]
10. The Framework for Human Host Immune Responses to Four Types of Parasitic Infections and Relevant Key JAK/STAT Signaling.
Wen TH; Tsai KW; Wu YJ; Liao MT; Lu KC; Hu WC
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948112
[TBL] [Abstract][Full Text] [Related]
11. Cytokine receptor splice variants in hematologic diseases.
Wang B; Mehta H
Cytokine; 2020 Mar; 127():154919. PubMed ID: 31816579
[TBL] [Abstract][Full Text] [Related]
12. Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.
Kandikattu HK; Upparahalli Venkateshaiah S; Mishra A
Cytokine Growth Factor Rev; 2019 Jun; 47():83-98. PubMed ID: 31126874
[TBL] [Abstract][Full Text] [Related]
13. "Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.
Bousoik E; Montazeri Aliabadi H
Front Oncol; 2018; 8():287. PubMed ID: 30109213
[TBL] [Abstract][Full Text] [Related]
14. Tributyltin exposure alters cytokine levels in mouse serum.
Lawrence S; Pellom ST; Shanker A; Whalen MM
J Immunotoxicol; 2016 Nov; 13(6):870-878. PubMed ID: 27602597
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-
Xie Q; Shen ZJ; Oh J; Chu H; Malter JS
J Clin Cell Immunol; 2011 Nov; Suppl 1():. PubMed ID: 24244891
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of interleukin-5 dimer recognition by its α receptor.
Kusano S; Kukimoto-Niino M; Hino N; Ohsawa N; Ikutani M; Takaki S; Sakamoto K; Hara-Yokoyama M; Shirouzu M; Takatsu K; Yokoyama S
Protein Sci; 2012 Jun; 21(6):850-64. PubMed ID: 22528658
[TBL] [Abstract][Full Text] [Related]
17. Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma.
Ghazi A; Trikha A; Calhoun WJ
Expert Opin Biol Ther; 2012 Jan; 12(1):113-8. PubMed ID: 22136436
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-5 and IL-5 receptor in health and diseases.
Takatsu K
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(8):463-85. PubMed ID: 21986312
[TBL] [Abstract][Full Text] [Related]
19. Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signaling.
Lei JT; Mazumdar T; Martinez-Moczygemba M
J Biol Chem; 2011 Nov; 286(46):40091-103. PubMed ID: 21965659
[TBL] [Abstract][Full Text] [Related]
20. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor.
Mori Y; Iwasaki H; Kohno K; Yoshimoto G; Kikushige Y; Okeda A; Uike N; Niiro H; Takenaka K; Nagafuji K; Miyamoto T; Harada M; Takatsu K; Akashi K
J Exp Med; 2009 Jan; 206(1):183-93. PubMed ID: 19114669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
